Vista Pharmaceuticals Board Meeting May 29 2026

• Vista Pharmaceuticals board meeting scheduled for May 29, 2026 to approve FY26 results.
• Meeting will consider audited financial results for quarter and year ended March 31, 2026.
• Board will review audit report for fiscal year 2025-26 ending March 31, 2026.
• Disclosure made under SEBI Listing Regulations Regulation 29(1)(a) to BSE.